✦ LIBER ✦

Insulin-dependent inhibition of hepatic glycogenolysis by gastric inhibitory polypeptide (GIP) in perfused rat liver

✍ Scribed by H. Hartmann; R. Ebert; W. Creutzfeldt

Publisher: Springer
Year: 1986
Tongue: English
Weight: 354 KB
Volume: 29
Category: Article
ISSN: 0012-186X
DOI: 10.1007/bf00456120

No coin nor oath required. For personal study only.

✦ Synopsis

The effect of porcine gastric inhibitory polypeptide on hepatic glycogen metabolism was investigated in the isolated in situ perfused rat liver. Glycogenolysis was stimulated by infusion of glucagon into the portal vein (half maximal effective portal vein concentration -30 pmol/1). When glucagon was infused at a final portal vein concentration of 0.5 nmol/1, simultaneous addition of insulin inhibited the glucagon-dependent glycogenolysis in a dose-dependent way (half maximal effective concentration for insulin about 2 nmol/1). Gastric inhibitory polypeptide alone at a concentration of 1 nmol/1 reduced glucagon-dependent glycogenolysis only slightly. However, when infused simultaneously at low insulin concentrations (0.1 nmol/1), gastric inhibitory polypeptide suppressed hepatic glucose production dose-dependently up to 70%. The data suggest that gastric inhibitory polypeptide exerts direct metabolic effects on hepatic glycogen metabolism predominantly in a situation where insulin is simultaneously present, e.g. following ingestion of glucose.

📜 SIMILAR VOLUMES

On the inhibition of hepatic glycogenoly

On the inhibition of hepatic glycogenolysis by fructose. A 31P-NMR study in perfused rat liver using the fructose analogue 2,5-anhydro-D-mannitol

✍ K. Bruynseels; N. Bergans; N. Gillis; F. van Dorpen; P. Van Hecke; W. Stalmans; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Inhibition of hormone-stimulated hepatic glycogenolysis by fructose (Fru) has been attributed to accumulation of the competitive inhibitor Fru1P and/or to the associated depletion of the substrate phosphate (P i ). To evaluate the relative importance of either factor, we used the Fru analogue 2,5-an

Dose-dependent inhibition of transporter

Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model

✍ Ridhi Parasrampuria; Reza Mehvar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

Methotrexate (MTX) and cyclosporine (CyA) are coadministered in a number of diseases. In this study, the effects of CyA on the hepatobiliary disposition of MTX were investigated in an isolated perfused rat liver model. A bolus 5-mg dose of MTX was added to a recirculating perfusate in the absence or